Hydrochloride is the active ingredient in medications containing memantine.
Treatment of moderate to severe Alzheimer's disease.
Symptomatic improvement of cognitive function and global function in patients with moderate to severe Alzheimer's disease.
Admenta Xr 7mg Tab (Memantine) is a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist. It modulates the effects of glutamate, a neurotransmitter involved in learning and memory, by blocking the NMDA receptor, reducing excitotoxicity, and improving synaptic plasticity. This action helps to improve cognitive function in patients with Alzheimer's disease.
Store at room temperature (below 25°C). Protect from moisture and light. Keep out of reach of children.
Dosage should be determined by a healthcare professional and adjusted based on individual patient needs and tolerance.
Typically, treatment starts with a low dose and is gradually increased over several weeks.
Available in various formulations including oral tablets and solutions.
Headache
Dizziness
Constipation
Nausea
Vomiting
Confusion
Somnolence
Hallucinations
Vertigo
High blood pressure
Alcohol should be avoided or consumed in moderation as it may exacerbate side effects.
Patients should avoid driving or operating machinery until they know how memantine affects their ability to perform these activities.
Use during pregnancy and breastfeeding is not recommended unless the potential benefits outweigh the risks. Consult a physician.
Not indicated for use in children.
Dose adjustment may be necessary for patients with impaired kidney function.
Dose adjustment may be necessary for patients with impaired liver function.
Please consult your physician or pharmacist for detailed information and refer to the official prescribing information provided with your medication.
